Edwards PASCAL Transcatheter Valve Repair System Registry

NCT04443218 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 220

Last updated 2024-07-26

Study results available
· View outcomes & findings →

Summary

This registry will collect prospective and retrospective clinical data on patients treated with the Edwards PASCAL Transcatheter Valve Repair System outside of the Post-Market Clinical Follow-up (PMCF) study.

Conditions

  • Mitral Valve Insufficiency

Interventions

DEVICE

Edwards PASCAL Transcatheter Valve Repair System

The Edwards PASCAL Valve Repair System is indicated for the percutaneous reconstruction of an insufficient mitral valve.

Sponsors & Collaborators

  • Edwards Lifesciences

    lead INDUSTRY

Principal Investigators

  • Joerg Hausleiter, Prof. · MD

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-27
Primary Completion
2021-05-10
Completion
2021-05-10

Countries

  • Germany
  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04443218 on ClinicalTrials.gov